First US sale for USCOM
Thursday, 28 July, 2005
Sydney-based devices company USCOM (ASX:UCM) has received its first US orders for its heart monitoring equipment. The USCOM Ultrasonic Cardiac Output Monitor, which the company says uses ultrasound technology to cost-effectively and non-invasively measure blood flow across the cardiac valves, was purchased by the Regional Healthcare System for Florida.
USCOM has also advanced the monitor's technology and the latest version of USCOM operating system software includes real-time calculation of beat-to-beat Systemic Vascular Resistance (SVR), a cardiovascular measure relating to cardiac output and blood pressure.
USCOM secured FDA approval to market the device in US in February and has had first sales in 11 other countries, including Australia.
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
Australia's first cases of H5 avian influenza confirmed
Positive results for H5 avian influenza (bird flu) have been confirmed in two seabirds found in...
